Diagnostic method for inborn errors of pyrimidine metabolism
Project/Area Number |
26860818
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Pediatrics
|
Research Institution | Fujita Health University |
Principal Investigator |
NAKAJIMA Yoko 藤田保健衛生大学, 医学部, 助教 (70598309)
|
Project Period (FY) |
2014-04-01 – 2016-03-31
|
Project Status |
Completed (Fiscal Year 2015)
|
Budget Amount *help |
¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
Fiscal Year 2015: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2014: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
|
Keywords | ピリミジン代謝異常症 / 尿中ピリミジン代謝物分析 / 5-フルオロウラシル / ハイリスクスクリーニング / UPLC-MS/MS / 遺伝子診断 / 先天性ピリミジン代謝異常症診断システム / 5FU関連抗癌剤代謝 / 5FU薬物代謝 / ハイリスクスクリーニンング |
Outline of Final Research Achievements |
Inborn errors of pyrimidine degradation pathway have wide clinical aspects and show very severe side effects of 5-fluorouracil related anticancer drugs. However, the details of these diseases, such as disease frequency or genetic mutations are unclear, because the number of reported patients is limited. In this study, we established the diagnostic system for inborn errors of pyrimidine degradation pathway by simultaneous analysis of urinary pyrimidine metabolites using UPLC-MS/MS followed by genetic analysis. The genetic analysis revealed that UPB1 R326Q mutation was identified in all patients with beta-ureidopropionase deficiency and 70% of these patients were homozygote of this mutation. Population study showed that 2% of healthy Japanese were carrier of the R326Q mutation. This result showed that beta-ureidopropionase deficiency is not as rare as generally considered in Japan.
|
Report
(3 results)
Research Products
(12 results)
-
-
-
-
[Journal Article] Clinical, biochemical and molecular analysis of 13 Japanese patients with β-ureidopropionase deficiency demonstrates high prevalence of the c.977G > A (p.R326Q) mutation2014
Author(s)
Nakajima Y, Meijer J, Dobritzsch D, Ito T, Meinsma R, Abeling NGGM, Roelofsen J, Zoetekouw L, Watanabe Y, Lee T, Mitsubuchi H, Yoneyama A, Ohta K, Kuhara T, Eto K, Saito K, van Kuilenburg ABP
-
Journal Title
J Inherit Metab Dis
Volume: 37
Issue: 5
Pages: 801-812
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
[Presentation] Clinical, biochemical and molecular analysis of 30 children with β-ureidoproionase deficiency demonstrates high prevalence of the c.977G>A(p.R326Q) mutation2015
Author(s)
Yoko Nakajima, Judith Meijer, Chunhua Zhang, Yoriko Watanabe, Tomoko Lee, Hiroshi Mitsubuchi, Kaoru Eto, Tomiko Kuhara, Tetsuya Ito, Andre van Kuilenburg
Organizer
16th international Symposium on Purine and Pyrimidine Metabolism in Man
Place of Presentation
New York, Columbia University
Year and Date
2015-06-06
Related Report
Int'l Joint Research
-
-
-
[Presentation] β-ウレイドプロピオナーゼ欠損症13例の生化学的・分子生物学的解析とUPB1遺伝子p.R326Q変異頻度の検討2014
Author(s)
Yoko Nakajima, Judith Meijer, Doreen Dobritzsch, Yoriko Watanabe, Tomiko Kuhara, Hiroshi Mitsubuchi, Tomoko Lee, Kaoru Eto, Tetsuya Ito, André B.P. van Kuilenburg
Organizer
第56回 日本先天代謝異常学会総会 / 第12回アジア先天代謝異常症シンポジウム
Place of Presentation
宮城県仙台市 江陽グランドホテル
Year and Date
2014-11-13 – 2014-11-15
Related Report
-
[Presentation] Clinical, biochemical and molecular analysis of 13 Japanese patients with β-ureidopropionase deficiency demonstrates high prevalence of the c.977G>A (p.R326Q) mutation2014
Author(s)
Yoko Nakajima, Judith Meijer, Doreen Dobritzsch, Tetsuya Ito, Rutger Meinsma, Lida Zoetekouw, Yoriko Watanabe, Kyoko Tashiro, Tomoko Lee, Yasuhiro Takeshima, Hiroshi Mitsubuchi, Akira Yoneyama, Kazuhide Ohta, Kaoru Eto, Kayoko Saito, Tomiko Kuhara, A.B.P. van Kuilenburg
Organizer
SSIEM Annual Symposium 2014
Place of Presentation
Innsbruck, Tyrol, Austria.
Year and Date
2014-09-02 – 2014-09-05
Related Report
-